0 TSX News - March 26, 2020REMINDER/Saputo Inc.: Conference call to provide an update on the impact of COVID-19 on activitiesMONTRÉAL, March 26, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will […]Read More
0 TSX News - March 26, 2020MediPharm Labs Launches New Line of High-Quality Branded Products Across CanadaBARRIE, Ontario, March 26, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]Read More
0 TSX Venture News - March 26, 2020DATAMETREX EXECUTES $1.1M IN NEW CONTRACTSTORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM) (FSE: D4G) (OTC: DTMXF) is pleased […]Read More
0 TSX Venture News - March 26, 2020Tetra Biopharma Survey Validates Primary Endpoint of SERENITY© Clinical TrialOTTAWA, March 26, 2020 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived […]Read More
0 TSX Venture News - March 26, 2020IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial ResultsSAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported [...]Read More
0 Canadian Stock Exchange News - March 26, 2020Draganfly Selected to Globally Integrate Breakthrough Health Diagnosis Technology Immediately onto Autonomous Camera’s and Specialized Drones to Combat Coronavirus (COVID-19) and Future Health EmergenciesPartnering with The University of South Australia developers of the technology in collaboration with the Australian Department of Defence – […]Read More
0 Canadian Stock Exchange News - March 26, 2020XORTX Announces New Clinical Advisory Board MemberCALGARY, Alberta, March 26, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]Read More
0 NASDAQ Companies - March 26, 2020Prevail Therapeutics Reports Full Year 2019 Financial Results and Business HighlightsDosing Initiated in PROPEL Phase 1/2 Trial of PR001 for Treatment of Parkinson’s Disease with GBA1 MutationsPreparations Underway to Initiate […]Read More
0 TSX Venture News - March 26, 2020Aldebaran Provides Update on Site Activities in Response to COVID-19VANCOUVER, British Columbia, March 26, 2020 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (“Aldebaran” or the “Company”, ALDE TSX.V) is providing […]Read More
0 NYSE Companies - March 26, 2020Worthington Reports Third Quarter Fiscal 2020 ResultsCOLUMBUS, Ohio, March 26, 2020 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) today reported net sales of $764.0 million […]Read More